Back to search results
Flavio G. Vincenti
Flavio G. Vincenti

Flavio G. Vincenti, MD

Transplant Nephrology | Pancreas Transplant Surgery

Kidney Transplant Center
400 Parnassus Ave., Seventh Floor,
San Francisco, CA 94143
+1 more location
Virtual visits available
Virtual visits available
Kidney Transplant Center
400 Parnassus Ave., Seventh Floor,
San Francisco, CA 94143
+1 more location

Dr. Flavio Vincenti is a specialist in kidney and pancreas transplantation. He came to UCSF Medical Center in 1975 for a fellowship in transplant nephrology and was appointed a member of the kidney transplant team.

In 1978, Vincenti co-authored an article in the New England Journal of Medicine on the role of blood transfusions in improving kidney transplants. He also wrote a series of articles on the complications of transplants and has been a leading investigator and writer on the use of anti–interleukin 2 receptor monoclonal antibodies, used to reduce the chance of organ rejection. In addition, he is a proponent of minimizing immunosuppressive drugs after transplants.

Vincenti is a member of many professional organizations, including the Transplantation Society, American Society of Nephrology, American Society of Transplantation and International Society of Nephrology. He is a co-leader of the Immune Tolerance Network's kidney section. In addition, he is on the editorial boards of Graft and the American Journal of Kidney Diseases.

  • Board Certifications

    American Board of Internal Medicine, Nephrology, 1976

    American Board of Internal Medicine, Internal Medicine, 1975

  • Internship

    AUB Medical Center, Nephrology, 1973

  • Education

    American University of Beirut Faculty of Medicine, 1971

  • Languages

    English

Conditions I specialize in

Treatments I provide

  • Dialysis

Where I see patients (2)

    Selected research

    See all research
    Decorative Caduceus

    Daratumumab and Belatacept for Desensitization

    Proportion of subjects who have not met a subject stopping rule, and remain free of all of the following through 26 weeks after starting treatment or until receiving a transplant, whichever occurs earlier: 1. Grade 3 or higher ...

    Recruiting

    Contact me

    Share